Published in Pharmacol Rep on September 22, 2014
Role of oxidative stress in Alzheimer's disease. Biomed Rep (2016) 0.95
Mitofusin-2 knockdown increases ER-mitochondria contact and decreases amyloid β-peptide production. J Cell Mol Med (2016) 0.85
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions. Front Pharmacol (2015) 0.82
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease. J Cell Mol Med (2016) 0.81
Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. Mol Neurodegener (2016) 0.80
Efficacy of Memantine in Schizophrenic Patients: A Systematic Review. J Amino Acids (2017) 0.79
Long noncoding RNAs and Alzheimer's disease. Clin Interv Aging (2016) 0.79
Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro. Mar Drugs (2016) 0.78
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools. Toxins (Basel) (2015) 0.78
New Drugs from Marine Organisms in Alzheimer's Disease. Mar Drugs (2015) 0.78
Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials. Int J Neuropsychopharmacol (2015) 0.78
The Eye As a Biomarker for Alzheimer's Disease. Front Neurosci (2016) 0.77
Protective effect of tetrahydroxy stilbene glucoside on learning and memory by regulating synaptic plasticity. Neural Regen Res (2016) 0.77
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies. Neural Plast (2016) 0.76
Studies on the In Vitro Antiproliferative, Antimicrobial, Antioxidant, and Acetylcholinesterase Inhibition Activities Associated with Chrysanthemum coronarium Essential Oil. Evid Based Complement Alternat Med (2015) 0.76
DNA Demethylation Upregulated Nrf2 Expression in Alzheimer's Disease Cellular Model. Front Aging Neurosci (2016) 0.76
Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles. Iran J Pharm Res (2016) 0.76
An Extract from Shrimp Processing By-Products Protects SH-SY5Y Cells from Neurotoxicity Induced by Aβ25-35. Mar Drugs (2017) 0.75
Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport. Mol Neurodegener (2017) 0.75
Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience. J Alzheimers Dis (2017) 0.75
Exposure to general anesthesia and the risk of dementia. J Pain Res (2015) 0.75
Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease. Sci Rep (2017) 0.75
Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments. Front Aging Neurosci (2016) 0.75
Biomaterials for the Treatment of Alzheimer's Disease. Front Bioeng Biotechnol (2016) 0.75
The prion protein family member Shadoo induces spontaneous ionic currents in cultured cells. Sci Rep (2016) 0.75
Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis. Mol Imaging Biol (2016) 0.75
Role of berberine in Alzheimer's disease. Neuropsychiatr Dis Treat (2016) 0.75
Association between alcohol and Alzheimer's disease. Exp Ther Med (2016) 0.75
AChE for DNA degradation. Cell Res (2015) 0.75
Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails. J Alzheimers Dis (2016) 0.75
Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40. Brain Inj (2016) 0.75
Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease. Chem Sci (2017) 0.75
Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease. Cell Mol Life Sci (2017) 0.75
Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis. PLoS One (2017) 0.75
Organosulfur compound protects against memory decline induced by scopolamine through modulation of oxidative stress and Na(+)/K(+) ATPase activity in mice. Metab Brain Dis (2017) 0.75
Cholinergic modulation of the hippocampal region and memory function. J Neurochem (2017) 0.75
Nature Versus Nurture: Does Proteostasis Imbalance Underlie the Genetic, Environmental, and Age-Related Risk Factors for Alzheimer's Disease? Healthcare (Basel) (2017) 0.75
Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease. CNS Drugs (2017) 0.75
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. J Med Chem (2017) 0.75
Optogenetics and its application in neural degeneration and regeneration. Neural Regen Res (2017) 0.75
Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats. J Clin Diagn Res (2017) 0.75
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro. Cell J (2017) 0.75
Panax quinquefolium involves nitric oxide pathway in olfactory bulbectomy rat model. Physiol Behav (2014) 0.78